TY - JOUR
T1 - Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum
AU - Illán-Gala, Ignacio
AU - Montal, Victor
AU - Pegueroles, Jordi
AU - Vilaplana, Eduard
AU - Alcolea, Daniel
AU - Dols-Icardo, Oriol
AU - Turón-Sans, Janina
AU - Cortés-Vicente, Elena
AU - Martinez-Roman, Luis
AU - Sánchez-Saudinós, Maria Belén
AU - Subirana, Andrea
AU - Videla, Laura
AU - Sala, Isabel
AU - Barroeta, Isabel
AU - Valldeneu, Sílvia
AU - Blesa, Rafael
AU - Clarimón, Jordi
AU - Lleó, Alberto
AU - Fortea, Juan
AU - Rojas-García, Ricard
N1 - Publisher Copyright:
Copyright © 2020 American Academy of Neurology
PY - 2020/11/3
Y1 - 2020/11/3
N2 - Objective To characterize the cortical macrostructure and microstructure of behavioral and cognitive changes along the amyotrophic lateral sclerosis (ALS)-frontotemporal dementia (FTD) continuum. Methods We prospectively recruited 88 participants with a 3T MRI structural and diffusion-weighted imaging sequences: 31 with ALS, 20 with the behavioral variant of FTD (bvFTD), and 37 cognitively normal controls. Participants with ALS underwent a comprehensive cognitive and behavioral assessment and were dichotomized into ALS without cognitive or behavioral impairment (ALSno-cbi; n = 12) and ALS with cognitive or behavioral impairment (ALScbi; n = 19). We computed cortical thickness and cortical mean diffusivity using a surface-based approach and explored the cortical correlates of cognitive impairment with the Edinburgh Cognitive and Behavioral ALS Screen. Results The ALSno-cbi and ALScbi groups showed different patterns of reduced cortical thickness and increased cortical mean diffusivity. In the ALSno-cbi group, cortical thinning was restricted mainly to the dorsal motor cortex. In contrast, in the ALScbi group, cortical thinning was observed primarily on frontoinsular and temporal regions bilaterally. There were progressive cortical mean diffusivity changes along the ALSno-cbi, ALScbi, and bvFTD clinical continuum. Participants with ALS with either cognitive or behavioral impairment showed increased cortical mean diffusivity in the prefrontal cortex in the absence of cortical thickness. Conclusions Cortical mean diffusivity might be a useful biomarker for the study of extramotor cortical neurodegeneration in the ALS-FTD clinical spectrum.
AB - Objective To characterize the cortical macrostructure and microstructure of behavioral and cognitive changes along the amyotrophic lateral sclerosis (ALS)-frontotemporal dementia (FTD) continuum. Methods We prospectively recruited 88 participants with a 3T MRI structural and diffusion-weighted imaging sequences: 31 with ALS, 20 with the behavioral variant of FTD (bvFTD), and 37 cognitively normal controls. Participants with ALS underwent a comprehensive cognitive and behavioral assessment and were dichotomized into ALS without cognitive or behavioral impairment (ALSno-cbi; n = 12) and ALS with cognitive or behavioral impairment (ALScbi; n = 19). We computed cortical thickness and cortical mean diffusivity using a surface-based approach and explored the cortical correlates of cognitive impairment with the Edinburgh Cognitive and Behavioral ALS Screen. Results The ALSno-cbi and ALScbi groups showed different patterns of reduced cortical thickness and increased cortical mean diffusivity. In the ALSno-cbi group, cortical thinning was restricted mainly to the dorsal motor cortex. In contrast, in the ALScbi group, cortical thinning was observed primarily on frontoinsular and temporal regions bilaterally. There were progressive cortical mean diffusivity changes along the ALSno-cbi, ALScbi, and bvFTD clinical continuum. Participants with ALS with either cognitive or behavioral impairment showed increased cortical mean diffusivity in the prefrontal cortex in the absence of cortical thickness. Conclusions Cortical mean diffusivity might be a useful biomarker for the study of extramotor cortical neurodegeneration in the ALS-FTD clinical spectrum.
UR - http://www.scopus.com/inward/record.url?scp=85095461698&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000010727
DO - 10.1212/WNL.0000000000010727
M3 - Article
C2 - 32913016
AN - SCOPUS:85095461698
SN - 0028-3878
VL - 95
SP - E2565-E2576
JO - Neurology
JF - Neurology
IS - 18
ER -